F4 FundFund
TeamPortfolioRaiseChampionsEssays
Sign in
Investment ThesisInvestment TeamF4 Research BriefSelected PortfolioRecent UpdatesFrequent co-investorsSimilar Firms
Hot Fund
#67 · Top 100 · 2026#13 · Biotech 50 · 2026

DCVC

dcvc.com · San Francisco, CA

“We back entrepreneurs using computational approaches (AI, simulation) to solve trillion-dollar problems in climate, health, industrial transformation, and national security. Deep tech requires patient capital and scientific rigor.”

$5M – $25M
Check Size
Leads
Lead Tendency
$4B
AUM
~2 Months
Timeline
01Investment Thesis

We back entrepreneurs using computational approaches (AI, simulation) to solve trillion-dollar problems in climate, health, industrial transformation, and national security. Deep tech requires patient capital and scientific rigor.

Exclusion Criteria

Not interested in consumer apps, purely software businesses without hard tech, or companies with short development timelines. We avoid commoditized markets and non-technical founding teams.

02Investment Team
ZB
Zachary Bogue
Co-Founder and Managing Partner
MO
Matthew Ocko
Co-Founder and Managing Partner
DJ
Dr. John Hamer
Managing Partner, DCVC Bio
DK
Dr. Kiersten Stead
Managing Partner, DCVC Bio
SP
Spencer Punter
Partner & COO
AC
Alan Cohen
General Partner
JH
James Hardiman
General Partner
JP
Jason Pontin
General Partner
03F4 Research Brief

DCVC Research Document

Investment Thesis

DCVC (Data Collective) is a deep tech venture capital firm focused on backing entrepreneurs who apply modern computation—particularly AI and simulation—to solve trillion-dollar problems in the real world. Founded in 2013, DCVC has become a pioneer in identifying and funding companies across industries that historically have seen little technological progress. Their investment philosophy centers on identifying hard science problems and leveraging computational approaches to achieve breakthrough innovations.

The firm's core belief is that venture capital, when done well, improves the common good. They back companies that address existential challenges in climate, human health, industrial transformation, and national security, while creating significant economic value for investors.

Stage and Check Size Focus

DCVC operates across multiple stages but shows strongest activity in Seed and Series A rounds:

  • Seed stage: $1M-$5M typical investments
  • Series A: $5M-$15M+ follow-on investments
  • Overall check size range: $5M-$25M (per firm data)

The firm maintains a longer-term investment horizon than traditional venture, recognizing that deep tech requires patient capital. They've invested in 200+ companies over their 13-year history, demonstrating sustained deployment across multiple funds.

Geographic and Sector Focus

Primary Geographies
  • United States (San Francisco, Palo Alto, NYC)
  • Africa (emerging markets focus)
  • Selective international: Canada, Europe
Investment Sectors and Themes

DCVC organizes their portfolio across 10 major content topics:

  1. Climate & Clean Energy - Largest focus area with companies like Fervo Energy (geothermal), Brimstone (carbon-negative cement), and Amogy (ammonia decarbonization)
  2. Computational Biology & Chemistry - AI-powered drug discovery and development
  3. Cybersecurity, Security & Defense - Portfolio includes SentinelOne (NYSE: S)
  4. Enterprise Enablement & Infrastructure - Data platforms and automation
  5. Finance & Insurance - Fintech and risk management
  6. Foundational Technology - Quantum computing and advanced semiconductors
  7. Industrial Transformation & Robotics - Agility Robotics, Sanctuary AI, and others
  8. Smart Agriculture - Precision farming and sustainability
  9. Space - Rocket Lab (Nasdaq: RKLB), Impulse Space, and others
  10. TechBio - Ginkgo Bioworks (NYSE: DNA), Evonetix, cell programming

Team and Decision-Making

DCVC is led by co-founders and Managing Partners Zachary Bogue and Matthew Ocko. The firm has 45 team members with a distinctive profile: more published scientists than MBAs. Most team members have founded or run successful companies, bringing operational expertise to their partnership model.

The decision-making process is partnership-based, with deep expertise distributed across the team. This allows for sophisticated technical evaluation of complex deep tech companies spanning quantum computing, molecular biology, materials science, and advanced physics.

Recent Activity and Fund Status

DCVC has been actively deploying capital across multiple funds:

Recent Notable Investments (2025-2026):
  • January 2026: Proxima raises $80M seed led by DCVC (protein-protein interaction therapeutics)
  • January 2026: Relation & Deerfield collaborate from DCVC portfolio (drug discovery AI)
  • 2025 Portfolio Achievements: GSK partnership with DCVC portfolio company Noetik, Radiant $350M Series D in advanced nuclear
Fund Portfolio Scale
  • 13 funds to date including 6 flagship funds and 3 specialized DCVC Bio funds
  • $4B+ Assets Under Management across all funds
  • 200+ companies invested in over their 13-year history

Lead Tendency and Investor Involvement

DCVC strongly leads or co-leads most of their investments. This reflects their confidence in their technical evaluation and desire to partner actively with founders. Portfolio exits include significant outcomes: AbCellera (Nasdaq: ABCL), Ginkgo Bioworks (NYSE: DNA), Planet (NYSE: PL), Rocket Lab (Nasdaq: RKLB), Confluent (Nasdaq: CFLT), Elastic (NYSE: ESTC), SentinelOne (NYSE: S), and Desktop Metal (NYSE: DM).

Portfolio Companies (Representative Sample)

From portfolio of 200+ companies spanning climate, biotech, robotics, quantum computing, space, and enterprise software, demonstrating their commitment to backing deep tech visionaries.

04Selected Portfolio
Aerospace & Defense
Rocket Lab·Radiant·Chariot Defense
AgTech & Agriculture
Pivot Bio
Biotech & Life Sciences
AbCellera·Ginkgo Bioworks·Recursion·Latus Bio·Quantum Motion·Sidewinder Therapeutics·Kanvas Biosciences
Climate & Sustainability
Fervo Energy·Desktop Metal
Developer Tools & Infrastructure
Databricks·CircleCI
E-commerce & Marketplaces
Emerald AI
Energy & Power
Oklo·Lunar Energy
Enterprise Software
Rigetti Computing·Confluent·Elastic·Planet·Get in touch
Manufacturing & Industrial
Brimstone
Marketing & Adtech
Proxima
Robotics & Automation
Agility Robotics·Sanctuary AI
Security & Cybersecurity
SentinelOne·SenseMesh
Semiconductors & Hardware
Atom Computing·Graphcore·Callosum
Other
Relation
Open the full portfolio→
05Recent Updates

Fresh signals from public announcements, essays, and portfolio activity.

See full activity (17) →
Portfolio company Radiant received a $750 million U.S. Army award for advanced nuclear microreactor development.
MILESTONE·dcvc.com
AUG 26, 2026
DCVC co-led Emerald AI's $150 million Series A round to transform data centers into intelligent grid-responsive assets.
INVESTMENT·dcvc.com
AUG 25, 2026
DCVC joined a $100 million seed round for Callosum, which is building a new orchestration layer for heterogeneous AI.
INVESTMENT·dcvc.com
AUG 20, 2026
Portfolio company Relation announced a strategic collaboration with GSK for its MORGAN cellular foundation model, worth up to $110 million in upfront and milestone payments.
MILESTONE·dcvc.com
JUL 30, 2026
DCVC published its fourth annual Deep Tech Opportunities Report, themed 'Back to Fundamentals in an Age of Exponential Change', covering energy, AI, quantum, manufacturing, drug discovery, robotics, and defense.
ESSAY·dcvc.com
JUL 1, 2026
06Frequent co-investors
PV
Prelude Ventures
Both backed 4 of the same companies
Pivot Bio, Atom Computing, Planet, Lunar Energy
AH
Andreessen Horowitz
Both backed 2 of the same companies
Databricks, Chariot Defense
B
Benchmark
Both backed 2 of the same companies
Elastic, Get in touch
CC
Casdin Capital
Both backed 2 of the same companies
Recursion, Ginkgo Bioworks
C
Coatue
Both backed 2 of the same companies
Databricks, Get in touch
Find the investors for your round→
07Similar Firms
M
Massive
$500K – $3M · Seed · Series A
→
VC
Vanedge Capital
$1M – $15M · Pre-Seed · Seed
→
AC
Amadeus Capital Partners
$1.3M – $12.7M · Seed · Series A
→
7V
7percent Ventures
$250K – $2M · Pre-Seed · Seed
→
AC
ACME Capital
$500K – $15M · Seed · Series A
→
Quick Reference
Check Size
$5M – $25M
Stages
Pre-Seed · Seed · Series A
AUM
$4B
Decision
Partnership · ~2 Months
Warm Intro
Preferred
Involvement
Board Seat
Location
San Francisco, CA
Sector Focus
Aerospace & DefenseBiotech & Life SciencesSemiconductors & HardwareRobotics & AutomationClimate & SustainabilityEnterprise SoftwareDeveloper Tools & InfrastructureHealthcare & Digital Health
Models
Deep TechAI/MLClimate TechBiotech
Technology
AI/MLSimulationQuantum Computing
See all Aerospace & Defense investors →See all Biotech & Life Sciences investors →See all Semiconductors & Hardware investors →
Visit dcvc.com ↗

See how DCVC matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Focus Areas
Aerospace & DefenseBiotech & Life SciencesSemiconductors & HardwareRobotics & AutomationClimate & SustainabilityEnterprise SoftwareDeveloper Tools & InfrastructureHealthcare & Digital Health

See how DCVC matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Is this your firm? Claim your profile
F4 Intelligence Report · Last Researched August 29, 2026F4 Research Engine